Cite

HARVARD Citation

    Bishop, A. et al. (2022). Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma. Journal of immunotherapy. 45 (8), pp. 374-378. [Online]. 
  
Back to record